CD8A and neoplasm: A better understanding of the tumor and its environment, in particular the knowledge that various immune cells, such as natural killer (NK) cells and CD8+ T cells, can infiltrate tumors and can act in concert to kill tumor cells, has fueled the development of novel cancer therapy strategies that aspire activation of the immune system.